ABU DHABI / GULF TIME As the world marks Sarcoma Awareness Month this July, leading ...
Read More »Chinese Alzheimer’s drug gets US approval for stateside trial
Bloomberg A Chinese drugmaker has received approval from the Food and Drug Administration (FDA) to start clinical trials in the US for a breakthrough Alzheimer’s drug as it seeks global validation for the controversial therapy. Shanghai Green Valley Pharmaceutical Co got clearance on April 8 for the US part of a global trial that seeks to enroll more than 2,000 ...
Read More »